Krista Noonan, BSc, MD, FRCPC / Elizabeth R. Plimack, MD, MS, FASCO - Redefining the Standards of Care in RCC: Expert Insights to Translate Recent Advances to Clinical Practice

What this episode covers

Visit https://www.peervoice.com/QZP860 to view the entire programme with slides. After completing “Krista Noonan, BSc, MD, FRCPC / Elizabeth R. Plimack, MD, MS, FASCO - Redefining the Standards of Care in RCC: Expert Insights to Translate Recent Advances to Clinical Practice”, participants will be able to: Discuss the role of immunotherapy in early-stage renal cell carcinoma (RCC); Propose strategies to explain adjuvant treatment to patients, to achieve a shared decision; Evaluate how prior treatments influence the choice of subsequent lines of therapy in advanced RCC; and Formulate evidence-based approaches for identifying and managing adverse events with new therapies for advanced RCC.

Distinct summary based on available episode metadata or transcript content.